The Alexandria of Torrey Pines
La Jolla, California

Welcome to LAII 2020

Our Mission

Long-acting injectables and implants improve the quality of life for patients living with diseases requiring chronic dosing. These life-changing injectables and implants are proven to increase efficacy and enhance patient and dosing compliance.
To meet this growing market need, a large variety of delivery technologies have been developed for all modalities across pharmaceutical products. The knowledge needed to translate from concept to laboratory to actual therapy for these delivery systems is rapidly evolving.
This conference’s goal is to provide attendees with insights into:

  • Clinical applications where long-acting injectable and implants can provide a benefit for the patient
  • Existing and new technologies in development
  • How to use advanced pharmacokinetic modeling in the definition of formulation

And much more…

-- Preliminary Agenda --

Linking Formulation to In Vivo Exposure Profile

STEVE SCHWENDEMAN – University of Michigan

  • Cage Model to Recover Particle and Correlate to PK

VIERA LUKACOVA – Simulations Plus, Inc.

  • TBA

DIANE BURGESS – University of Connecticut

  • IVIVC for Small Molecules

Process Engineering

JUKKA RANTANEN – University of Copenhagen

  • Processing of Nano-Suspension

TOM TICE – Evonik

  • Microsphere Formulation

Devices for Injectable Systems

MARK PRAUSNITZ – Georgia Institute of Technology

  • Microneedle Device for Long-Acting Contraceptive Hormone

OMID VEISEH – William Marsh Rice University

  • TBA

Implantable Systems

TEJAL DESAI – University of California, San Francisco

  • Titanium Implants

CHARLES W. FLEXNER – Johns Hopkins University

  • Long-Acting and Extended Release Product Development for HIV and Related Infections

VED SRIVASTAVA – Intarcia Therapeutics

  • Research Programs Update

DAVID FRIEND – Daré Bioscience, Inc.

  • TBA

TASSOS NICOLAOU – Delpor

  • Prozor Technology

RAJ PATEL – Titan Pharmaceuticals

  • Probuphine Product Development

Delivery/Controlled Release

WIM HENNICK – Utrecht University

  • Protein Delivery in Hydrogel for Ocular Delivery

WIM JISKOOT – Leiden University

  • Protein Characterization Polymer/Immunogenicity

JON POKORSKI – University of California, San Diego

  • Melt-Processing of Several Protein Candidates

HONGWEN RIVERS – Allergan

  • To Develop Long-Acting Complex Dosage Forms of Biologics for the Eye: Opportunities and Challenges

Formulations

SHENG QI – University of East Anglia

  • TBA

KARSTEN MÄDER – Martin-Luther-University Halle-Wittenberg

  • Parenteral Controlled Release In Vivo

FREDERIC DARGELAS – DelSiTech

  • Protein Formulations in Silica Particles

Sponsorship Opportunities

LAII offers several sponsorship packages for companies looking for brand exposure, separated into levels such as Platinum, Gold, and Silver.  For more information on sponsorship opportunities please read our LAII 2020 Sponsorship Prospectus or reach out to us:

2020 Planning Committee

Nima Akhavein, GSK
Maria Josè Alonso, USC
Rene Holm, Janssen
Julius Korley, University of Delaware
Jui-Chen Lin, Drug Delivery Experts
Laxma Reddy, Drug Delivery Experts
Chris Rhodes, Drug Delivery Experts
Steve Schwendeman, University of Michigan
An Vermeulen, Janssen

Registration Coming Soon!

To stay up to date on LAII 2020, please leave your contact information below.

Contact Form

Name

Company

Email

Message